Cargando…
Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy
This retrospective pooled analysis aims to identify factors predicting relapse despite a pathologic complete response (pCR) in patients with breast cancer (BC). 2066 patients with a pCR from five neoadjuvant GBG/AGO-B trials fulfill the inclusion criteria of this analysis. Primary endpoint is diseas...
Autores principales: | Huober, Jens, van Mackelenbergh, Marion, Schneeweiss, Andreas, Seither, Fenja, Blohmer, Jens-Uwe, Denkert, Carsten, Tesch, Hans, Hanusch, Claus, Salat, Christoph, Rhiem, Kerstin, Solbach, Christine, Fasching, Peter A., Jackisch, Christian, Reinisch, Mattea, Lederer, Bianca, Mehta, Keyur, Link, Theresa, Nekljudova, Valentina, Loibl, Sibylle, Untch, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082019/ https://www.ncbi.nlm.nih.gov/pubmed/37029138 http://dx.doi.org/10.1038/s41523-023-00525-2 |
Ejemplares similares
-
Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto
por: Laakmann, Elena, et al.
Publicado: (2019) -
Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto Trial
por: Gerber, Bernd, et al.
Publicado: (2022) -
Outcome after neoadjuvant chemotherapy in elderly breast cancer patients – a pooled analysis of individual patient data from eight prospectively randomized controlled trials
por: von Waldenfels, Gabriel, et al.
Publicado: (2018) -
HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer
por: Denkert, Carsten, et al.
Publicado: (2013) -
Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC
por: Massa, Chiara, et al.
Publicado: (2020)